Prostate Cancer:@0.762090:0.035749:0.914561:0.035749:0.914561:0.019993:0.762090:0.019993:0.011392:0.005709:0.012604:0.007466:0.006523:0.013143:0.006523:0.012508:0.005330:0.015644:0.013143:0.011738:0.012450:0.012508:0.005792
TREATMENT APPROACHES:@0.983689:0.278245:0.983689:0.065272:0.955679:0.065272:0.955679:0.278245:0.000000:0.000000:0.000000:0.057096:-0.123230:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.375913
63:@0.955522:0.038184:0.976595:0.038184:0.976595:0.018587:0.955522:0.018587:0.010536:0.010536
HANDBOOK OF ONCOLOGY:@0.679047:0.970015:0.915156:0.970015:0.915156:0.956010:0.679047:0.956010:0.011682:0.012657:0.012657:0.012726:0.009818:0.014864:0.014864:0.010109:0.004738:0.014864:0.008296:0.004738:0.014864:0.012657:0.013906:0.014864:0.007902:0.014864:0.014915:0.010126
TREATMENT OPTIONS:@0.084848:0.096077:0.313918:0.096077:0.313918:0.076481:0.084848:0.076481:0.009878:0.013641:0.012230:0.017404:0.009878:0.021167:0.012230:0.017404:0.009878:0.006585:0.019756:0.013170:0.009878:0.006585:0.019756:0.017404:0.012230
Traditional thinking such as local, locally :@0.084848:0.114567:0.481049:0.114567:0.481049:0.098811:0.084848:0.098811:0.007620:0.005792:0.013143:0.013181:0.003848:0.006523:0.003848:0.012604:0.011738:0.013143:0.003848:0.009660:0.006523:0.011738:0.003848:0.011738:0.009660:0.003848:0.011738:0.012950:0.009660:0.007466:0.011699:0.012450:0.011738:0.009660:0.013143:0.007466:0.009660:0.003848:0.012604:0.012450:0.013143:0.003848:0.005330:0.009660:0.003848:0.012604:0.012450:0.013143:0.003848:0.003848:0.010314:0.005330
advanced  and metastatic is useful, but :@0.084848:0.130760:0.481061:0.130760:0.481061:0.115004:0.084848:0.115004:0.013143:0.013181:0.010660:0.013143:0.011738:0.012450:0.012508:0.013181:0.005330:0.004957:0.013143:0.011738:0.013181:0.010275:0.018049:0.012508:0.006523:0.013143:0.007466:0.006523:0.013143:0.006523:0.003848:0.012450:0.010275:0.003848:0.007466:0.010275:0.011699:0.007466:0.012508:0.006042:0.011699:0.003848:0.005330:0.010275:0.013123:0.011699:0.006523:0.005330
when  patients  are  classified  in  the  risk :@0.084848:0.146952:0.481082:0.146952:0.481082:0.131196:0.084848:0.131196:0.015990:0.011738:0.012508:0.011738:0.005330:0.007379:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330:0.007385:0.013143:0.005715:0.012508:0.005330:0.007383:0.012450:0.003848:0.013143:0.007466:0.007466:0.003848:0.004686:0.004686:0.012508:0.013193:0.005330:0.007385:0.003848:0.011738:0.005330:0.007387:0.006523:0.011738:0.012508:0.005330:0.007378:0.005792:0.003848:0.007466:0.009660:0.005330
groups set out in Table 2, treatment  op-:@0.084848:0.163145:0.475758:0.163145:0.475758:0.147389:0.084848:0.147389:0.012950:0.005709:0.012604:0.011699:0.013123:0.007466:0.009044:0.007466:0.012508:0.006523:0.009044:0.012604:0.011699:0.006523:0.009044:0.003848:0.011738:0.009044:0.007197:0.013143:0.013123:0.003848:0.012508:0.009044:0.010660:0.005330:0.009044:0.006523:0.005711:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.003704:0.012604:0.013123:0.006388
tions can be better selected.:@0.084848:0.179337:0.354608:0.179337:0.354608:0.163581:0.084848:0.163581:0.006523:0.003848:0.012604:0.011738:0.007466:0.005330:0.012450:0.013143:0.011738:0.005330:0.013123:0.012508:0.005330:0.013123:0.012508:0.006523:0.006523:0.012508:0.005792:0.005330:0.007466:0.012508:0.003848:0.012508:0.012450:0.006523:0.012508:0.013181:0.005330
When  a  patient  suffers  metastatic  dis-:@0.103032:0.195530:0.475750:0.195530:0.475750:0.179774:0.103032:0.179774:0.018473:0.011738:0.012508:0.011738:0.005330:0.004580:0.013143:0.005330:0.004589:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.005330:0.004587:0.007466:0.011699:0.006100:0.006042:0.012508:0.005792:0.007466:0.005330:0.004584:0.018049:0.012508:0.006523:0.013143:0.007466:0.006523:0.013143:0.006523:0.003848:0.012450:0.005330:0.004589:0.013181:0.003848:0.007466:0.006388
ease, the intent must be clear: prolonged :@0.084848:0.211722:0.481128:0.211722:0.481128:0.195966:0.084848:0.195966:0.012508:0.013143:0.007466:0.012508:0.005330:0.005946:0.006523:0.011738:0.012508:0.005936:0.003848:0.011738:0.006523:0.012508:0.011738:0.006523:0.005934:0.018049:0.011699:0.007466:0.006523:0.005946:0.013123:0.012508:0.005946:0.012450:0.003848:0.012508:0.013143:0.005792:0.005330:0.005931:0.013123:0.005715:0.012604:0.003848:0.012604:0.011738:0.012950:0.012508:0.013181:0.005330
survival,  symptom control or supportive :@0.084848:0.227915:0.481090:0.227915:0.481090:0.212159:0.084848:0.212159:0.007466:0.011699:0.005792:0.010660:0.003848:0.010660:0.013143:0.003848:0.005330:0.005330:0.007460:0.007466:0.010314:0.018049:0.013123:0.006523:0.012604:0.018049:0.012777:0.012450:0.012604:0.011738:0.006523:0.005703:0.012604:0.003848:0.012777:0.012604:0.005792:0.012777:0.007466:0.011699:0.013123:0.013123:0.012604:0.005792:0.006523:0.003848:0.010660:0.012508:0.005330
care only. See Figure 1 for an algorithm for :@0.084848:0.244107:0.481099:0.244107:0.481099:0.228351:0.084848:0.228351:0.012450:0.013143:0.005713:0.012508:0.004965:0.012604:0.011738:0.003848:0.010314:0.005330:0.004965:0.009583:0.012508:0.012508:0.004965:0.009333:0.003848:0.012950:0.011699:0.005709:0.012508:0.004965:0.010660:0.004965:0.006042:0.012604:0.005792:0.004965:0.013143:0.011738:0.004965:0.013143:0.003848:0.012950:0.012604:0.005792:0.003848:0.006523:0.011738:0.018049:0.004965:0.006042:0.012604:0.005792:0.005330
the treatment of prostate cancer.:@0.084848:0.260300:0.398367:0.260300:0.398367:0.244544:0.084848:0.244544:0.006523:0.011738:0.012508:0.005330:0.006523:0.005700:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.012604:0.006042:0.005330:0.013123:0.005696:0.012604:0.007466:0.006523:0.013143:0.006523:0.012508:0.005330:0.012450:0.013143:0.011738:0.012450:0.012508:0.004366:0.005330
ACTIVE SURVEILLANCE:@0.084848:0.293057:0.311909:0.293057:0.311909:0.275241:0.084848:0.275241:0.015822:0.016677:0.008980:0.005987:0.014966:0.011118:0.005987:0.011118:0.013683:0.012401:0.014966:0.011118:0.005987:0.009407:0.009407:0.015822:0.015822:0.016677:0.011118
Patients eligible for active surveillance :@0.084848:0.310400:0.481069:0.310400:0.481069:0.294644:0.084848:0.294644:0.011392:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.014547:0.012508:0.003848:0.003848:0.012950:0.003848:0.013123:0.003848:0.012508:0.014547:0.006042:0.012604:0.005792:0.014547:0.013143:0.012450:0.006523:0.003848:0.010660:0.012508:0.014547:0.007466:0.011699:0.005792:0.010660:0.012508:0.003848:0.003848:0.003848:0.013143:0.011738:0.012450:0.012508:0.005330
have very low-risk disease.:@0.084848:0.326593:0.329208:0.326593:0.329208:0.310837:0.084848:0.310837:0.011738:0.013143:0.010660:0.012508:0.005330:0.010660:0.012508:0.005792:0.010314:0.005330:0.003848:0.012604:0.015990:0.006388:0.005792:0.003848:0.007466:0.009660:0.005330:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.005330
Advantages of  this approach  is the :@0.103032:0.342785:0.481107:0.342785:0.481107:0.327029:0.103032:0.327029:0.014239:0.013181:0.010660:0.013143:0.011738:0.006523:0.013143:0.012950:0.012508:0.007466:0.014374:0.012604:0.006042:0.005330:0.009032:0.006523:0.011738:0.003848:0.007466:0.014374:0.013143:0.013123:0.013123:0.005719:0.012604:0.013143:0.012450:0.011738:0.005330:0.009032:0.003848:0.007466:0.014374:0.006523:0.011738:0.012508:0.005330
delay of  interventional  treatment  – e.g., :@0.084848:0.358978:0.481107:0.358978:0.481107:0.343222:0.084848:0.343222:0.013181:0.012508:0.003848:0.013143:0.010314:0.009583:0.012604:0.006042:0.005330:0.004241:0.003848:0.011738:0.006523:0.012508:0.005792:0.010660:0.012508:0.011738:0.006523:0.003848:0.012604:0.011738:0.013143:0.003848:0.005330:0.004239:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.004239:0.009621:0.009685:0.012508:0.005330:0.012950:0.005330:0.005330:0.005330
 :@0.424644:0.358978:0.430032:0.358978:0.430032:0.342944:0.424644:0.342944:0.005388
radical  prostatectomy, external beam :@0.084848:0.375170:0.481096:0.375170:0.481096:0.359414:0.084848:0.359414:0.005792:0.013143:0.013181:0.003848:0.012450:0.013143:0.003848:0.005330:0.011384:0.013123:0.005715:0.012604:0.007466:0.006523:0.013143:0.006523:0.012508:0.012450:0.006523:0.012604:0.018049:0.010314:0.005330:0.016702:0.012508:0.009236:0.006523:0.012508:0.006192:0.011738:0.013143:0.003848:0.016702:0.013123:0.012508:0.013143:0.018049:0.005330
radiation  therapy (EBRT)  and  hormonal :@0.084848:0.391363:0.481094:0.391363:0.481094:0.375607:0.084848:0.375607:0.005792:0.013143:0.013181:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.007243:0.006523:0.011738:0.012508:0.005792:0.013133:0.013123:0.010314:0.012585:0.007100:0.010314:0.011045:0.011801:0.008197:0.007100:0.005330:0.007243:0.013143:0.011738:0.013181:0.005330:0.007245:0.011738:0.012604:0.006315:0.018049:0.012604:0.011738:0.013143:0.003848:0.005330
management deferring the treatment to :@0.084848:0.407555:0.481097:0.407581:0.481097:0.391826:0.084848:0.391799:0.018049:0.013143:0.011738:0.013143:0.012950:0.012508:0.018049:0.012508:0.011738:0.006523:0.017192:0.013181:0.012508:0.006042:0.012508:0.005792:0.005792:0.003848:0.011738:0.012950:0.005296:0.006523:0.011738:0.012508:0.005301:0.006523:0.005713:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005299:0.006523:0.012604:0.408850
 – :@0.215186:0.407420:0.232409:0.407420:0.232409:0.392539:0.215186:0.392539:0.004514:0.008178:0.004531
avoid side effects,  but  still treating  cura-:@0.084857:0.423774:0.475782:0.423774:0.475782:0.408018:0.084857:0.408018:0.013143:0.010660:0.012604:0.003848:0.013181:0.008717:0.007466:0.003848:0.013181:0.012508:0.008717:0.012508:0.006098:0.006042:0.012508:0.012450:0.006523:0.007466:0.005330:0.005330:0.003375:0.013123:0.011699:0.006523:0.005330:0.003375:0.007466:0.006523:0.003848:0.003848:0.003848:0.008717:0.006523:0.005709:0.012508:0.013143:0.006523:0.003848:0.011738:0.012950:0.005330:0.003375:0.012450:0.011699:0.005792:0.013143:0.006388
tively when indicated.:@0.084857:0.439966:0.290943:0.439966:0.290943:0.424211:0.084857:0.424211:0.006523:0.003848:0.010660:0.012508:0.003848:0.010314:0.005330:0.015990:0.011738:0.012508:0.011738:0.005330:0.003848:0.011738:0.013181:0.003848:0.012450:0.013143:0.006523:0.012508:0.013181:0.005330
The  advantages of  active surveillance :@0.542441:0.096154:0.920493:0.096154:0.920493:0.080398:0.542441:0.080398:0.008197:0.011738:0.012508:0.005330:0.004297:0.013143:0.013181:0.010660:0.013143:0.011738:0.006523:0.013143:0.012950:0.012508:0.007466:0.009640:0.012604:0.006042:0.005330:0.004301:0.013143:0.012450:0.006523:0.003848:0.010660:0.012508:0.009640:0.007466:0.011699:0.005792:0.010660:0.012508:0.003848:0.003848:0.003848:0.013143:0.011738:0.012450:0.012508:0.005330
include prevention, avoidance of danger :@0.524257:0.112346:0.920501:0.112346:0.920501:0.096590:0.524257:0.096590:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.012508:0.006032:0.013123:0.005715:0.012508:0.010660:0.012508:0.011738:0.006523:0.003848:0.012604:0.011738:0.005330:0.006025:0.013143:0.010660:0.012604:0.003848:0.013181:0.013143:0.011738:0.012450:0.012508:0.006031:0.012604:0.006042:0.006027:0.013181:0.013143:0.011738:0.012950:0.012508:0.005792:0.005330
of anaesthesia and complications during :@0.524257:0.127652:0.920507:0.127652:0.920507:0.111896:0.524257:0.111896:0.012604:0.006042:0.007514:0.013143:0.011738:0.013143:0.012508:0.007466:0.006523:0.011738:0.012508:0.007466:0.003848:0.013143:0.007524:0.013143:0.011738:0.013181:0.007524:0.012450:0.012604:0.018049:0.013123:0.003848:0.003848:0.012450:0.013143:0.006523:0.003848:0.012604:0.011738:0.007466:0.007524:0.013181:0.011699:0.005792:0.003848:0.011738:0.012950:0.005330
surgery  (i.e.,  erectile  dysfunction  [ED],  in-:@0.524257:0.142958:0.915163:0.142958:0.915163:0.127203:0.524257:0.127203:0.007466:0.011699:0.005809:0.012950:0.012508:0.005792:0.010314:0.005330:0.003060:0.007100:0.003848:0.005330:0.012508:0.005330:0.005330:0.005330:0.003061:0.012508:0.005711:0.012508:0.012450:0.006523:0.003848:0.003848:0.012508:0.005330:0.003065:0.013181:0.010314:0.007466:0.006042:0.011699:0.011738:0.012450:0.006523:0.003848:0.012604:0.011738:0.005330:0.003063:0.006754:0.010314:0.014316:0.006754:0.005330:0.005330:0.003069:0.003848:0.011738:0.006388
continence,  rectal damage); radiother-:@0.524257:0.158265:0.915167:0.158265:0.915167:0.142509:0.524257:0.142509:0.012450:0.012604:0.011738:0.006523:0.003848:0.011738:0.012508:0.011738:0.012450:0.012508:0.005330:0.005330:0.006785:0.005713:0.012508:0.012450:0.006523:0.013143:0.003848:0.012142:0.013181:0.013143:0.018049:0.013143:0.012950:0.012508:0.007100:0.005330:0.012142:0.005792:0.013143:0.013181:0.003848:0.012604:0.006523:0.011738:0.012508:0.005763:0.006388
apy damage to surrounding organs (i.e., :@0.524257:0.173571:0.920495:0.173571:0.920495:0.157815:0.524257:0.157815:0.013143:0.013123:0.010314:0.008140:0.013181:0.013143:0.018049:0.013143:0.012950:0.012508:0.008130:0.006523:0.012604:0.008128:0.007466:0.011699:0.005792:0.005711:0.012604:0.011699:0.011738:0.013181:0.003848:0.011738:0.012950:0.008124:0.012604:0.005792:0.012950:0.013143:0.011738:0.007466:0.008140:0.007100:0.003848:0.005330:0.012508:0.005330:0.005330:0.005330
bladder and kidneys and ED in some pa-:@0.524257:0.188877:0.915186:0.188877:0.915186:0.173121:0.524257:0.173121:0.013123:0.003848:0.013143:0.013181:0.013181:0.012508:0.005792:0.006831:0.013143:0.011738:0.013181:0.006831:0.009660:0.003848:0.013181:0.011738:0.012508:0.010314:0.007466:0.006831:0.013143:0.011738:0.013181:0.006831:0.010314:0.014316:0.006831:0.003848:0.011738:0.006831:0.007466:0.012604:0.018049:0.012508:0.006831:0.013123:0.013143:0.006388
tients), hormonal issues with ED, osteopo-:@0.524257:0.204183:0.915167:0.204183:0.915167:0.188427:0.524257:0.188427:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.007100:0.005330:0.007505:0.011738:0.012604:0.006317:0.018049:0.012604:0.011738:0.013143:0.003848:0.007505:0.003848:0.007466:0.007466:0.011699:0.012508:0.007466:0.007505:0.015990:0.003848:0.006523:0.011738:0.007505:0.010314:0.014316:0.005330:0.007505:0.012604:0.007466:0.006523:0.012508:0.012604:0.013123:0.012579:0.006388
rosis, depression and gynaecomastia.:@0.524257:0.219489:0.874102:0.219489:0.874102:0.203733:0.524257:0.203733:0.005713:0.012604:0.007466:0.003848:0.007466:0.005330:0.005330:0.013181:0.012508:0.013123:0.005715:0.012508:0.007466:0.007466:0.003848:0.012604:0.011738:0.005330:0.013143:0.011738:0.013181:0.005330:0.012950:0.010314:0.011738:0.013143:0.012508:0.012450:0.012604:0.018049:0.013143:0.007466:0.006523:0.003848:0.013143:0.005330
Disadvantages of active surveillance :@0.542441:0.234795:0.920476:0.234795:0.920476:0.219039:0.542441:0.219039:0.014124:0.003656:0.007274:0.012950:0.012989:0.010468:0.012950:0.011545:0.006331:0.012950:0.012758:0.012315:0.007274:0.017164:0.012411:0.005850:0.017164:0.012950:0.012257:0.006331:0.003656:0.010468:0.012315:0.017164:0.007274:0.011507:0.005600:0.010468:0.012315:0.003656:0.003656:0.003656:0.012950:0.011545:0.012257:0.012506:0.005330
are anxiety and depression from frequent :@0.524257:0.250101:0.920485:0.250101:0.920485:0.234346:0.524257:0.234346:0.012950:0.005521:0.012315:0.007658:0.012950:0.011545:0.009044:0.003656:0.012315:0.006331:0.010122:0.007658:0.012950:0.011545:0.012989:0.007658:0.012989:0.012315:0.012931:0.005521:0.012315:0.007274:0.007274:0.003656:0.012411:0.011545:0.007658:0.005850:0.005519:0.012411:0.017857:0.007658:0.005850:0.005521:0.012315:0.012931:0.011507:0.012315:0.011545:0.006521:0.005330
investigations, sepsis and infections from re-:@0.524257:0.265408:0.915180:0.265408:0.915180:0.249652:0.524257:0.249652:0.003656:0.011545:0.010468:0.012315:0.007274:0.006331:0.003656:0.012758:0.012950:0.006331:0.003656:0.012411:0.011545:0.007274:0.005138:0.004541:0.007274:0.012315:0.012931:0.007274:0.003656:0.007274:0.004541:0.012950:0.011545:0.012989:0.004541:0.003656:0.011545:0.005850:0.012315:0.012257:0.006331:0.003656:0.012411:0.011545:0.007274:0.004541:0.005850:0.005519:0.012411:0.017857:0.004541:0.005521:0.012315:0.006388
peated biopsies and higher mortality due :@0.524257:0.280714:0.920495:0.280714:0.920495:0.264958:0.524257:0.264958:0.012931:0.012315:0.012950:0.006331:0.012315:0.012989:0.007562:0.012931:0.003656:0.012411:0.012931:0.007274:0.003656:0.012315:0.007274:0.007562:0.012950:0.011545:0.012989:0.007562:0.011545:0.003656:0.012758:0.011545:0.012315:0.005600:0.007562:0.017857:0.012411:0.005600:0.006331:0.012950:0.003656:0.003656:0.006331:0.010122:0.007562:0.012989:0.011507:0.012506:0.005330
to disease progression in some patients.:@0.524257:0.296020:0.884797:0.296020:0.884797:0.280264:0.524257:0.280264:0.006331:0.012411:0.005138:0.012989:0.003656:0.007274:0.012315:0.012950:0.007274:0.012315:0.005138:0.012931:0.005521:0.012411:0.012758:0.005519:0.012315:0.007274:0.007274:0.003656:0.012411:0.011545:0.005138:0.003656:0.011545:0.005138:0.007274:0.012411:0.017857:0.012315:0.005138:0.012931:0.012950:0.006331:0.003656:0.012315:0.011545:0.006331:0.007274:0.005330
Surveillance implies PSA evaluation every :@0.542441:0.311326:0.920499:0.311326:0.920499:0.295570:0.542441:0.295570:0.009005:0.011122:0.005215:0.010083:0.011930:0.003271:0.003271:0.003271:0.012565:0.011161:0.011873:0.011930:0.008120:0.003271:0.017472:0.012546:0.003271:0.003271:0.011930:0.006889:0.008120:0.010814:0.009005:0.013662:0.008120:0.011930:0.010083:0.012565:0.003271:0.011122:0.012565:0.005946:0.003271:0.012027:0.011161:0.008120:0.011930:0.010083:0.011930:0.005215:0.010316:0.005330
three to six months, annual DRE and multipar-:@0.524257:0.326632:0.915180:0.326632:0.915180:0.310876:0.524257:0.310876:0.005946:0.011161:0.005136:0.011930:0.011930:0.004010:0.005946:0.012027:0.004010:0.006889:0.003271:0.008659:0.004010:0.017472:0.012027:0.011161:0.005946:0.011161:0.006889:0.004753:0.004010:0.012565:0.011161:0.011161:0.011122:0.012565:0.003271:0.004010:0.013739:0.011103:0.009737:0.004010:0.012565:0.011161:0.012604:0.004010:0.017472:0.011122:0.003271:0.005946:0.003271:0.012546:0.012565:0.005215:0.006388
ametric MRI, as well as annual biopsy. :@0.524257:0.342825:0.860093:0.342825:0.860093:0.327069:0.524257:0.327069:0.012565:0.017472:0.011930:0.005946:0.005215:0.003271:0.011873:0.004753:0.017106:0.011103:0.003772:0.004753:0.004753:0.012565:0.006889:0.004753:0.015413:0.011930:0.003271:0.003271:0.004753:0.012565:0.006889:0.004753:0.012565:0.011161:0.011161:0.011122:0.012565:0.003271:0.004753:0.012546:0.003271:0.012027:0.012546:0.006889:0.009737:0.005328:0.005330
The  following  criteria  define  clinically  sig-:@0.524257:0.375196:0.915163:0.375196:0.915163:0.359441:0.524257:0.359441:0.008197:0.011738:0.012508:0.005330:0.003019:0.006042:0.012604:0.003848:0.003848:0.012604:0.015990:0.003848:0.011738:0.012950:0.005330:0.003029:0.012450:0.005792:0.003848:0.006523:0.012508:0.005792:0.003848:0.013143:0.005330:0.003025:0.013181:0.012508:0.004686:0.004686:0.011738:0.012508:0.005330:0.003019:0.012450:0.003848:0.003848:0.011738:0.003848:0.012450:0.013143:0.003848:0.003848:0.010314:0.005330:0.003048:0.007466:0.003848:0.012950:0.006388
nificant progression::@0.524257:0.391389:0.709448:0.391389:0.709448:0.375633:0.524257:0.375633:0.011738:0.003848:0.004686:0.004686:0.012450:0.013143:0.011738:0.006523:0.005330:0.013123:0.005705:0.012604:0.012950:0.005707:0.012508:0.007466:0.007466:0.003848:0.012604:0.011738:0.005330
n   :@0.524242:0.404478:0.547050:0.404478:0.547050:0.396038:0.524242:0.396038:0.009762:0.003566:0.005914:0.003566
PSA progression: PSA doubling time in :@0.543484:0.407597:0.896448:0.407597:0.896448:0.391841:0.543484:0.391841:0.011392:0.009583:0.014239:0.005330:0.013123:0.005703:0.012604:0.012950:0.005707:0.012508:0.007466:0.007466:0.003848:0.012604:0.011738:0.005330:0.005330:0.011392:0.009583:0.014239:0.005330:0.013181:0.012604:0.011699:0.013123:0.003848:0.003848:0.011738:0.012950:0.005330:0.006523:0.003848:0.018049:0.012508:0.005330:0.003848:0.011738:0.005330
less than three years based on multiple :@0.543484:0.423790:0.910639:0.423790:0.910639:0.408034:0.543484:0.408034:0.003848:0.012508:0.007466:0.007466:0.005330:0.006523:0.011738:0.013143:0.011738:0.005330:0.006523:0.011738:0.005705:0.012508:0.012508:0.005330:0.010314:0.012508:0.013143:0.005792:0.007466:0.005330:0.013123:0.013143:0.007466:0.012508:0.013181:0.005330:0.012604:0.011738:0.005330:0.018049:0.011699:0.003848:0.006523:0.003848:0.013123:0.003848:0.012508:0.005330
PSA readings at three-monthly intervals:@0.543484:0.439982:0.905930:0.439982:0.905930:0.424226:0.543484:0.424226:0.011392:0.009583:0.014239:0.005330:0.005702:0.012508:0.013143:0.013181:0.003848:0.011738:0.012950:0.007466:0.005330:0.013143:0.006523:0.005330:0.006523:0.011738:0.005705:0.012508:0.012508:0.006388:0.018049:0.012604:0.011738:0.006523:0.011738:0.003848:0.010314:0.005330:0.003848:0.011738:0.006523:0.012508:0.005792:0.010660:0.013143:0.003848:0.007466
Figure 1. Algorithm for the treatment of prostate cancer:@0.084545:0.468229:0.559538:0.468229:0.559538:0.451838:0.084545:0.451838:0.009756:0.005272:0.011257:0.011218:0.007158:0.010160:0.003887:0.010680:0.005003:0.003887:0.012506:0.005292:0.011257:0.011103:0.007312:0.005272:0.007062:0.011276:0.016548:0.003887:0.006369:0.011103:0.007312:0.003887:0.007062:0.011276:0.010160:0.003887:0.007062:0.007156:0.010160:0.010006:0.007062:0.016548:0.010160:0.011161:0.007062:0.003887:0.011103:0.006562:0.003887:0.011507:0.007156:0.011103:0.008351:0.007062:0.010006:0.006966:0.010160:0.003887:0.008755:0.010160:0.011276:0.008467:0.010160:0.007312
Prostate cancer:@0.425629:0.497436:0.550589:0.497436:0.550589:0.482293:0.425629:0.482293:0.009159:0.005234:0.010468:0.007197:0.004907:0.010795:0.004907:0.010468:0.004580:0.010468:0.010795:0.009814:0.010468:0.010468:0.005234
Low risk:@0.140007:0.596442:0.201179:0.596442:0.201179:0.581299:0.140007:0.581299:0.007197:0.010468:0.013085:0.004580:0.005234:0.003925:0.007197:0.009487
High risk:@0.530278:0.596442:0.596357:0.596442:0.596357:0.581299:0.530278:0.581299:0.011122:0.003925:0.010795:0.009814:0.004580:0.005234:0.003925:0.007197:0.009487
Pain control:@0.711102:0.596442:0.804659:0.596442:0.804659:0.581299:0.711102:0.581299:0.009159:0.010795:0.003925:0.009814:0.004580:0.010468:0.010468:0.009814:0.004907:0.005234:0.010468:0.003925
New drugs:@0.694848:0.713130:0.778918:0.713130:0.778918:0.697987:0.694848:0.697987:0.012103:0.010468:0.013085:0.004580:0.010795:0.005234:0.009814:0.010795:0.007197
Intermediate risk:@0.342053:0.596442:0.474210:0.596442:0.474210:0.581299:0.342053:0.581299:0.004580:0.009814:0.004907:0.010468:0.005234:0.015375:0.010468:0.010795:0.003925:0.010795:0.004907:0.010468:0.004580:0.005234:0.003925:0.007197:0.009487
Non-metastatic:@0.112483:0.543657:0.235857:0.543657:0.235857:0.528776:0.112483:0.528776:0.012103:0.010713:0.009977:0.005430:0.015342:0.010631:0.005545:0.011171:0.006346:0.005545:0.011171:0.005545:0.003271:0.010582
• Watch and wait:@0.123479:0.629305:0.265076:0.629305:0.265076:0.614424:0.123479:0.614424:0.009912:0.004531:0.014887:0.011171:0.005545:0.010582:0.009977:0.004531:0.011171:0.009977:0.011204:0.004531:0.013592:0.011171:0.003271:0.005545
•  Active :@0.123479:0.643998:0.193646:0.643998:0.193646:0.629117:0.123479:0.629117:0.009912:0.004531:0.000000:0.012103:0.010582:0.005545:0.003271:0.009061:0.010631:0.004531
surveillance:@0.137921:0.658691:0.231003:0.658691:0.231003:0.643811:0.137921:0.643811:0.006346:0.009944:0.004923:0.009061:0.010631:0.003271:0.003271:0.003271:0.011171:0.009977:0.010582:0.010631
•  Surgery   radical :@0.123479:0.673384:0.265449:0.673384:0.265449:0.658504:0.123479:0.658504:0.009912:0.004531:0.000000:0.008145:0.009944:0.004936:0.011008:0.010631:0.004923:0.008767:0.004531:0.000000:0.004531:0.004923:0.011171:0.011204:0.003271:0.010582:0.011171:0.003271:0.004531
prostectomy:@0.137921:0.688078:0.238117:0.688078:0.238117:0.673197:0.137921:0.673197:0.011155:0.004856:0.010713:0.006346:0.005545:0.010631:0.010582:0.005545:0.010713:0.015342:0.008767
•  Radiotherapy:@0.123479:0.702771:0.246378:0.702771:0.246378:0.687890:0.123479:0.687890:0.009912:0.004531:0.000000:0.009928:0.011171:0.011204:0.003271:0.010713:0.005545:0.009977:0.010631:0.004923:0.011171:0.011155:0.008767
  •   Hormonal therapy for those who have poor performance status:@0.123449:0.892916:0.658726:0.892916:0.658726:0.878035:0.123449:0.878035:0.004531:-0.004531:0.009912:0.004531:0.004531:0.012228:0.011171:0.010713:0.005375:0.015342:0.010713:0.009977:0.011171:0.003271:0.004531:0.005545:0.009977:0.010631:0.004923:0.011171:0.011155:0.008767:0.004531:0.005136:0.010713:0.004923:0.004531:0.005545:0.009977:0.010713:0.006346:0.010631:0.004531:0.013592:0.009977:0.010713:0.004531:0.009977:0.011171:0.009061:0.010631:0.004531:0.011155:0.010713:0.010713:0.004923:0.004531:0.011155:0.010631:0.005702:0.005136:0.010713:0.005376:0.015342:0.011171:0.009977:0.010582:0.010631:0.004531:0.006346:0.005545:0.011171:0.005545:0.009944:0.006346
±:@0.137889:0.896100:0.150565:0.896100:0.150565:0.873756:0.137889:0.873756:0.012677
 :@0.150562:0.893903:0.154651:0.893903:0.154651:0.879834:0.150562:0.879834:0.004089
Metastatic:@0.709404:0.543657:0.794243:0.543657:0.794243:0.528776:0.709404:0.528776:0.015031:0.010631:0.005545:0.011171:0.006346:0.005545:0.011171:0.005545:0.003271:0.010582
EBRT-RA/ MRT:@0.192641:0.740375:0.301055:0.740375:0.301055:0.725495:0.192641:0.725495:0.008767:0.009388:0.010023:0.006968:0.005430:0.009928:0.012103:0.007147:0.006639:0.015031:0.010021:0.006968
I:@0.262394:0.741279:0.269037:0.741279:0.269037:0.724959:0.262394:0.724959:0.006643
Brachytherapy  pd:@0.192636:0.769774:0.336504:0.769774:0.336504:0.754894:0.192636:0.754894:0.009388:0.004923:0.011171:0.010582:0.009977:0.008767:0.005545:0.009977:0.010631:0.004923:0.011171:0.011155:0.008767:0.004531:0.000000:0.011155:0.011204
103:@0.336507:0.764467:0.352355:0.764467:0.352355:0.755791:0.336507:0.755791:0.005283:0.005283:0.005283
Brachytherapy + EBRT Rx:@0.403796:0.787673:0.597203:0.787673:0.597203:0.772792:0.403796:0.772792:0.009388:0.004923:0.011171:0.010582:0.009977:0.008767:0.005545:0.009977:0.010631:0.004923:0.011171:0.011155:0.008767:0.004531:0.009912:0.004531:0.008767:0.009388:0.010023:0.006968:0.004531:0.009928:0.007851
Hormonal therapy:@0.403796:0.817072:0.548230:0.817072:0.548230:0.802191:0.403796:0.802191:0.011171:0.010713:0.005375:0.015342:0.010713:0.009977:0.011171:0.003271:0.004531:0.005545:0.009977:0.010631:0.004923:0.011171:0.011155:0.008767
1:@0.294705:0.861901:0.303766:0.861901:0.303766:0.847020:0.294705:0.847020:0.009061
125:@0.303770:0.856594:0.319618:0.856594:0.319618:0.847919:0.303770:0.847919:0.005283:0.005283:0.005283
Surgery:@0.334705:0.640853:0.393060:0.640853:0.393060:0.625972:0.334705:0.625972:0.008145:0.009944:0.004936:0.011008:0.010631:0.004923:0.008767
EBRT-RA/ MRT:@0.334705:0.670252:0.443121:0.670251:0.443121:0.655370:0.334705:0.655371:0.008767:0.009388:0.010023:0.006968:0.005430:0.009928:0.012103:0.007148:0.006639:0.015031:0.010023:0.065126
I:@0.404458:0.671154:0.411101:0.671154:0.411101:0.654834:0.404458:0.654834:0.006643
EBRT-RA/ MRT:@0.531069:0.632835:0.639483:0.632835:0.639483:0.617954:0.531069:0.617954:0.008767:0.009388:0.010023:0.006968:0.005430:0.009928:0.012103:0.007148:0.006639:0.015031:0.010021:0.006968
I:@0.600821:0.633738:0.607464:0.633738:0.607464:0.617418:0.600821:0.617418:0.006643
+ Hormonal:@0.531063:0.662234:0.623239:0.662234:0.623239:0.647353:0.531063:0.647353:0.009912:0.004531:0.011171:0.010713:0.005375:0.015342:0.010713:0.009977:0.011171:0.003271
therapy:@0.531063:0.676927:0.593233:0.676927:0.593233:0.662046:0.531063:0.662046:0.005545:0.009977:0.010631:0.004923:0.011171:0.011155:0.008767
• Carbazitaxel:@0.708038:0.743570:0.822890:0.743570:0.822890:0.728689:0.708038:0.728689:0.009912:0.004531:0.013297:0.011171:0.004923:0.011155:0.011171:0.006951:0.003271:0.005545:0.011171:0.007851:0.010631:0.003271
•  Enzalutamide – post :@0.708038:0.758263:0.885256:0.758263:0.885256:0.743382:0.708038:0.743382:0.009912:0.004531:0.000000:0.008767:0.009977:0.006951:0.011171:0.003271:0.009944:0.005545:0.011171:0.015342:0.003271:0.011204:0.010631:0.004531:0.008178:0.004531:0.011155:0.010713:0.006346:0.005545:0.004531
progression on:@0.722480:0.772956:0.837575:0.772956:0.837575:0.758076:0.722480:0.758076:0.011155:0.004856:0.010713:0.011008:0.004856:0.010631:0.006346:0.006346:0.003271:0.010713:0.009977:0.004531:0.010713:0.009977
•  Alpharadin-Ra  for :@0.708038:0.787649:0.882920:0.787667:0.882920:0.772786:0.708038:0.772769:0.009912:0.004531:0.000000:0.012103:0.003271:0.011155:0.009977:0.011171:0.004923:0.011171:0.011204:0.003271:0.009977:0.005430:0.009928:0.011171:0.015852:0.004531:0.005136:0.010713:0.004923:-0.547897
223:@0.837233:0.782360:0.853081:0.782360:0.853081:0.773685:0.837233:0.773685:0.005283:0.005283:0.005283
bone mets:@0.722483:0.802360:0.807355:0.802360:0.807355:0.787480:0.722483:0.787480:0.011155:0.010713:0.009977:0.010631:0.004531:0.015342:0.010631:0.005545:0.006346
Radiotherapy:@0.696060:0.633503:0.804517:0.633503:0.804517:0.618623:0.696060:0.618623:0.009928:0.011171:0.011204:0.003271:0.010713:0.005545:0.009977:0.010631:0.004923:0.011171:0.011155:0.008767
Hormonal treatment:@0.696060:0.648196:0.857566:0.648196:0.857566:0.633316:0.696060:0.633316:0.011171:0.010713:0.005375:0.015342:0.010713:0.009977:0.011171:0.003271:0.004531:0.005545:0.004854:0.010631:0.011171:0.005545:0.015342:0.010631:0.009977:0.005545
Bisphosphonates:@0.696060:0.662890:0.828773:0.662890:0.828773:0.648009:0.696060:0.648009:0.009388:0.003271:0.006346:0.011155:0.009977:0.010713:0.006346:0.011155:0.009977:0.010713:0.009977:0.011171:0.005545:0.010631:0.006346
Chemo/surgery:@0.696060:0.677583:0.819725:0.677583:0.819725:0.662702:0.696060:0.662702:0.013297:0.009977:0.010631:0.015342:0.010713:0.007148:0.006346:0.009944:0.004936:0.011008:0.010631:0.004923:0.008767
taxotere:@0.178557:0.839140:0.245501:0.839140:0.245501:0.824259:0.178557:0.824259:0.005545:0.011171:0.007851:0.010713:0.005545:0.010631:0.004856:0.010631
IMRT - intensity-modulated radiotherapy; RA - RapidArc; EBRT - external beam radiation therapy:@0.087417:0.920434:0.876012:0.920434:0.876012:0.906429:0.087417:0.906429:0.003866:0.015719:0.010482:0.007286:0.004738:0.005679:0.004738:0.003421:0.010434:0.005798:0.011118:0.010434:0.006636:0.003421:0.005798:0.009168:0.005679:0.016044:0.011203:0.011716:0.010399:0.003421:0.011682:0.005798:0.011118:0.011716:0.004738:0.005148:0.011682:0.011716:0.003421:0.011203:0.005798:0.010434:0.011118:0.005148:0.011682:0.011665:0.009168:0.004738:0.004738:0.010382:0.012657:0.004738:0.005679:0.004738:0.010382:0.011682:0.011665:0.003421:0.011716:0.012657:0.005000:0.011067:0.004738:0.004738:0.009168:0.009818:0.010482:0.007286:0.004738:0.005679:0.004738:0.011118:0.008210:0.005798:0.011118:0.005490:0.010434:0.011682:0.003421:0.004738:0.011665:0.011118:0.011682:0.016044:0.004738:0.005148:0.011682:0.011716:0.003421:0.011682:0.005798:0.003421:0.011203:0.010434:0.004738:0.005798:0.010434:0.011118:0.005148:0.011682:0.011665:0.009168